Operating cash flow exhibits extreme lumpiness, highlighted by a 2024Q4 cash flow to net income ratio of 10,666.67, reflecting the inherent volatility of reinsurance premium and claim cycles.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 |
|---|
| Cash from Operations | 5.54B | 4.09B | 9.37B | 4.04B | 1.34B | 4.18B | 3.32B | 2.31B | 1.58B | 1.98B | 1.47B | 2.09B | 2.34B | 1.73B | 1.97B | 1.31B | 1.84B | 1.36B | 726.98M | 957.41M | 846.23M |
| Operating CF Growth % | -48.16% | -56.34% | 131.7% | 201.12% | -67.89% | 25.89% | 44% | 45.91% | -20.24% | 35.24% | -29.82% | -10.6% | 35.26% | -12.53% | 50.78% | -28.94% | 35.07% | 87.66% | -24.07% | 13.14% | - |
| Operating CF / Revenue % | 30.01% | 17.26% | 42.38% | 21.78% | 8.28% | 25.12% | 22.77% | 16.13% | 12.28% | 15.84% | 12.72% | 20.05% | 21.42% | 16.81% | 20.09% | 14.83% | 22304.61% | 24.01% | 12.8% | 16.74% | 16.29% |
| Net Income | 896.33M | 1.18B | 717M | 902M | 517M | 617M | 415M | 870M | 715.84M | 1.82B | 701.44M | 502.17M | 684.05M | 418.84M | 631.89M | 599.62M | 574.4M | 407.09M | 176.8M | 293.83M | 288.21M |
| Depreciation & Amortization | 0 | 0 | -168M | 389M | 375M | 0 | 589M | 605M | 45.13M | 52.9M | 26.85M | 26.6M | 18.91M | 167.58M | 182.76M | -172.69M | -144.33M | -134.52M | -89.94M | -75.66M | -53.34M |
| Stock-Based Compensation | 0 | 0 | 0 | 46M | 45M | 0 | -12M | 39M | 30M | 22M | 33.1M | 16M | 24.4M | 20.3M | 28.5M | -4.93M | 2.25M | 0 | 0 | 0 | 23.7M |
| Deferred Taxes | 0 | 0 | -61M | 211M | 0 | 0 | 0 | 0 | 76.51M | -847.3M | 293.78M | 149M | 170.73M | 230.78M | 198.11M | 186.23M | 444.15M | -81.19M | 47.62M | 101.76M | 189.58M |
| Other Non-Cash Items | 2.32B | -258M | 283M | -721M | -270M | -742M | -655M | -587M | 172.15M | -860.53M | 190.2M | 172.42M | -2.79M | -66.63M | 1.16B | 701.3M | 966.27M | 1.17B | 592.51M | 637.47M | 398.08M |
| Working Capital Changes | 2.82B | 3.17B | 8.6B | 3.22B | 676M | 4.31B | 2.98B | 1.38B | 738.26M | 1.07B | 600.93M | 1.37B | 1.61B | 1.19B | -285.19M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -14.1B | -12.09B | -12.54B | -4.07B | -5.69B | -4.63B | -2.68B | -2.64B | -636.55M | -1.61B | -2.83B | -1.43B | -1.31B | -1.34B | -1.97B | -905.78M | -1.72B | -1.94B | -1.07B | -976.87M | -1.63B |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | -19M | -28M | -34M | -28.89M | -44.21M | -44.64M | -23.55M | -88.36M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | -137M | -315M | 4M | -31.44M | 0 | 0 | -145.24M | 0 | -2.81M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchase of Investments | -33.64B | 0 | -41.68B | -13.25B | 0 | -19.35B | 0 | 0 | -10.86B | -10.05B | -9.17B | -5.87B | -6.13B | -46.51M | -6.82B | -4.01B | -4.85B | -4.69B | -2.73B | -2.82B | -3.47B |
| Sale/Maturity of Investments | 24.13B | 0 | 28.93B | 8.55B | 0 | 14.48B | 0 | 0 | 10.64B | 8.61B | 6.49B | 5.46B | 4.31B | 3.63B | 5.47B | 3.17B | 3.32B | 2.95B | 1.77B | 2.04B | 1.91B |
| Other Investing | -4.58B | -12.09B | 209M | 634M | -5.69B | 397M | -2.34B | -2.61B | -365.24M | -121.21M | -97.79M | -1.26B | -1.22B | -1.33B | -1.97B | -59.27M | -185.52M | -197.96M | -118.23M | -190.68M | -82.22M |
| Cash from Financing | 8.4B | 8.8B | 3.66B | 78M | 4.44B | 20M | 1.25B | -121M | -321.97M | -324.62M | 1.06B | -708.28M | -255.56M | -681.21M | 281.94M | 102M | -193.43M | 195M | 841.16M | 258.5M | 817.88M |
| Dividends Paid | -242M | -240M | -229M | -219M | -205M | -194M | -182M | -163M | -140.11M | -117.29M | -100.37M | -93.38M | -87.26M | -77.64M | -61.95M | -44.23M | -35.17M | -26.21M | -23.33M | -22.26M | -22.04M |
| Share Repurchases | -192M | -174M | -27M | -227M | -81M | -99M | -163M | -101M | -299.68M | -43.51M | -122.92M | -384.52M | -201.53M | -269.2M | -6.92M | -380.35M | -718K | -1.61M | -3.1M | -4.5M | -194K |
| Stock Issued | 4M | 4M | 0 | 0 | 0 | 0 | 0 | 0 | 3.46M | 7.29M | 15.32M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 331.88M | 0 | 0 |
| Debt Issuance (Net) | -3M | 1000K | 1000K | 1000K | 1000K | -1000K | 1000K | 1000K | -1000K | -1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 1000K | 0 | 1000K | 1000K |
| Other Financing | 9.46B | 8.55B | 3.31B | 62M | 4.62B | 430M | 1.22B | 38M | 213.4M | 199.9M | 530.42M | -367.74M | -361.75M | -610.2M | -39.85M | 456.53M | -159.82M | -117.33M | 529.12M | 55.76M | 93.64M |
| Net Change in Cash | -158M | 842M | 356M | 43M | -21M | -460M | 1.96B | -441M | 586.21M | 102.81M | -324.56M | -120.39M | 722.02M | -336.25M | 297.02M | 499.21M | -48.37M | -363.38M | 471.05M | 243.92M | 31.74M |
| Exchange Rate Effect | 6M | 47M | -130M | -13M | -112M | -34M | 63M | 11M | -36M | 53M | -19.94M | -68.99M | -47.63M | -47.09M | 8.55M | -6.54M | 22.8M | 16.45M | -23.93M | 4.89M | 1.99M |
| Cash at Beginning | 4.17B | 3.33B | 2.97B | 2.93B | 2.95B | 3.41B | 1.45B | 1.89B | 1.3B | 1.2B | 1.53B | 1.65B | 923.65M | 1.26B | 962.87M | 463.66M | 512.03M | 875.4M | 404.35M | 160.43M | 128.69M |
| Cash at End | 4.99B | 4.17B | 3.33B | 2.97B | 2.93B | 2.95B | 3.41B | 1.45B | 1.89B | 1.3B | 1.2B | 1.53B | 1.65B | 923.65M | 1.26B | 962.87M | 463.66M | 512.03M | 875.4M | 404.35M | 160.43M |
| Free Cash Flow | 5.54B | 4.09B | 9.37B | 4.59B | 1.34B | 4.16B | 3.29B | 2.27B | 1.55B | 1.94B | 1.42B | 2.07B | 2.25B | 1.73B | 1.97B | 1.31B | 1.84B | 1.36B | 726.98M | 957.41M | 846.23M |
| FCF Growth % | -52.96% | -56.34% | 103.92% | 242.14% | -67.74% | 26.38% | 44.92% | 46.43% | -19.91% | 36.38% | -31.18% | -8.13% | 30.14% | -12.53% | 50.78% | -28.94% | 35.07% | 87.66% | -24.07% | 13.14% | - |
| FCF Margin % | 30.01% | 17.26% | 42.38% | 24.75% | 8.28% | 25% | 22.57% | 15.89% | 12.06% | 15.49% | 12.33% | 19.82% | 20.61% | 16.81% | 20.09% | 14.83% | 22304.61% | 24.01% | 12.8% | 16.74% | 16.29% |
| FCF per Share | - | 61.06 | 139.85 | 68.48 | 19.84 | 60.95 | 50.06 | 35.58 | 23.85 | 29.48 | 21.87 | 30.69 | 32.13 | 23.84 | 26.63 | 17.85 | 24.67 | - | - | - | - |
Actuarial assumption volatility
As reported in quarterly financial disclosures, RZB's underwriting cash flow demonstrates significant variance, with operating cash flows reaching as high as $7.8 billion in 2024Q3, reflecting the inherent lumpiness of reinsurance premium inflows relative to the steady, high-volume outflow of policy claims and benefits.
The wide swings in operating cash flow suggest that RZB's liquidity position is heavily influenced by the timing of large treaty renewals rather than a linear accumulation of premiums. Investors should monitor the relationship between these cash inflows and the consistent $3.7 billion to $5.1 billion quarterly claims burden, which indicates that the company must maintain substantial liquid reserves to manage potential biometric shocks.
Based on the provided cash flow data, RZB maintains an active investment strategy, with quarterly purchase volumes peaking at $30.9 billion in 2024Q3, suggesting a high degree of portfolio turnover as the company seeks to optimize yields against its long-duration life insurance liabilities.
The frequent and large-scale movement of capital into and out of the investment portfolio implies that RZB is aggressively managing its asset-liability duration gap. This high turnover may indicate that the company is actively repositioning its fixed-income holdings to capture higher reinvestment rates, though it also introduces potential market risk if asset sales are forced during periods of liquidity stress.
According to the company's reported figures, the ratio of operating cash flow to net income has shown extreme volatility, with a peak of 10,666.67 in 2024Q4, highlighting the significant disconnect between GAAP net income and actual cash generation within the reinsurance business model.
This massive divergence suggests that non-cash accounting adjustments, particularly those related to LDTI and reserve changes, are heavily distorting the reported bottom line. Analysts should prioritize cash flow metrics over net income, as the latter appears to be an unreliable indicator of the company's true ability to generate distributable capital.
As evidenced by recent financial filings, RZB has maintained a consistent dividend payout of approximately $56 million to $61 million per quarter, suggesting a conservative approach to capital returns that prioritizes balance sheet stability over aggressive share repurchases during periods of fluctuating underwriting performance.
The company's ability to sustain dividends while simultaneously managing variable buyback activity indicates a management team focused on maintaining a capital buffer. However, the occasional net inflow from share activity, such as the $38 million in 2025Q2, warrants further investigation into whether this reflects opportunistic repurchases or a temporary pause in capital return to preserve liquidity.
Quick answers to the most common questions about buying RZB stock.
Reinsurance Group of America, Incorporated (RZB) generated $4.09B in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Reinsurance Group of America, Incorporated (RZB) generated $4.09B in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Reinsurance Group of America, Incorporated (RZB) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, Reinsurance Group of America, Incorporated (RZB) returned $240.0M to shareholders via cash dividends and spent $174.0M on share repurchases. This shows the company's commitment to returning capital to its equity investors.